Trial intelligence / Profile preview

Oxytocin PK/PD Model for Peripheral Pain

NCT04433741Phase 2Withdrawn

Sponsor
Wake Forest University Health Sciences
Start
Jan 2025
Primary completion
Dec 2025
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of oxytocin in chronic pain, sponsored by Wake Forest University Health Sciences. Planned start Jan 2025; status: withdrawn.

02

Drugs

oxytocin
03

Conditions

chronic pain

Beyond the preview

Go deeper on NCT04433741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04433741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call